Your browser doesn't support javascript.
loading
Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation.
Sula Karreci, Esilida; Eskandari, Siawosh K; Dotiwala, Farokh; Routray, Sujit K; Kurdi, Ahmed T; Assaker, Jean Pierre; Luckyanchykov, Pavlo; Mihali, Albana B; Maarouf, Omar; Borges, Thiago J; Alkhudhayri, Abdullah; Patel, Kruti R; Radwan, Amr; Ghobrial, Irene; McGrath, Martina; Chandraker, Anil; Riella, Leonardo V; Elyaman, Wassim; Abdi, Reza; Lieberman, Judy; Azzi, Jamil.
  • Sula Karreci E; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Eskandari SK; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Dotiwala F; Program in Cellular and Molecular Medicine, Boston Children's Hospital.
  • Routray SK; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Kurdi AT; Department of Medical Oncology, Dana-Farber Cancer Institute, and.
  • Assaker JP; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Luckyanchykov P; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Mihali AB; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Maarouf O; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Borges TJ; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Alkhudhayri A; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Patel KR; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Massachusetts, USA.
  • Radwan A; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Ghobrial I; Department of Medical Oncology, Dana-Farber Cancer Institute, and.
  • McGrath M; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Chandraker A; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Riella LV; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Elyaman W; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Massachusetts, USA.
  • Abdi R; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
  • Lieberman J; Program in Cellular and Molecular Medicine, Boston Children's Hospital.
  • Azzi J; Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Children's Hospital.
JCI Insight ; 2(21)2017 11 02.
Article en En | MEDLINE | ID: mdl-29093262
ABSTRACT
Tregs hold great promise as a cellular therapy for multiple immunologically mediated diseases, given their ability to control immune responses. The success of such strategies depends on the expansion of healthy, suppressive Tregs ex vivo and in vivo following the transfer. In clinical studies, levels of transferred Tregs decline sharply in the blood within a few days of the transfer. Tregs have a high rate of apoptosis. Here, we describe a new mechanism of Treg self-inflicted damage. We show that granzymes A and -B (GrA and GrB), which are highly upregulated in human Tregs upon stimulation, leak out of cytotoxic granules to induce cleavage of cytoplasmic and nuclear substrates, precipitating apoptosis in target cells. GrA and GrB substrates were protected from cleavage by inhibiting granzyme activity in vitro. Additionally, we show - by using cytometry by time of flight (CYTOF) - an increase in GrB-expressing Tregs in the peripheral blood and renal allografts of transplant recipients undergoing rejection. These GrB-expressing Tregs showed an activated phenotype but were significantly more apoptotic than non-GrB expressing Tregs. This potentially novel finding improves our understanding of Treg survival and suggests that manipulating Gr expression or activity might be useful for designing more effective Treg therapies.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Granzimas Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Granzimas Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article